Zuga Matt 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Zuga Matt
CFO & Chief Business Officer
Transactions
- Sale
Common Stock
2024-01-18$3.71/sh−4,242$15,717→ 211,445 total
Footnotes (1)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2023.